Cancer Prevention Research《癌症预防研究》(可网站投稿)

Cancer Prevention Research《癌症预防研究》(月刊). Cancer Prevention Research publishes original studies, reviews, and commentaries in the fields of cancer prevention and interception. The journal comprises preclinical, clinical, translational, and implementation research, with special attention given to molecular discoveries and an emphasis on building translational and mechanistic bridges between the basic, clinical, and population sciences.

杂志简称:cancer prev res
中文译名:《癌症预防研究》
收录属性:scie(2024版), 目次收录(维普), 目次收录(知网),英文期刊,
自引率:3.40%
投稿方向:医学、oncology肿瘤学

Cancer Prevention Research《癌症预防研究》

SCI/E期刊基本信息

出版周期:月刊 地区:美国
中科院分区:3区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:非OA期刊
国际标准刊号:ISSN 1940-6207;EISSN 1940-6215
杂志语言:英语
出版国家:美国

杂志官网 联系方式

出版地址:615 CHESTNUT ST,17TH FLOOR,PHILADELPHIA,USA,PA,19106-4404
杂志邮箱:
投稿网址:https://capr.msubmit.net/
杂志官方网址:http://cancerpreventionresearch.aacrjournals.org/
出版商网址:http://www.aacr.org

杂志投稿要求

投稿须知【杂志社官方网站信息】

About Cancer Prevention Research

Scope

Cancer Prevention Research publishes original studies, reviews, and commentaries in the fields of cancer prevention and interception. The journal comprises preclinical, clinical, translational, and implementation research, with special attention given to molecular discoveries and an emphasis on building translational and mechanistic bridges between the basic, clinical, and population sciences. The editors welcome manuscript submissions that describe mechanisms of carcinogenesis; develop preventive interventions to intercept cancer development at early stages; or evaluate implementation of evidence-based preventive practices. In-scope areas of particular interest follow:

Biology of susceptibility and premalignancy, including mechanistic studies to understand cancer formation and identify molecular targets for cancer prevention.

Risk factors, particularly the following: microbiome and viruses; chronic infection; behavioral and psychosocial factors (including diet, alcohol, vaping/tobacco, and inactivity); obesity; inflammation; metabolism; hormones; genetic risk factors; aging; and environmental carcinogens (including radiation and sunlight).

Multimorbidities of cancer and other chronic diseases, including studies on common pathways that can be targeted both for cancer prevention as well as for overall health improvement.

Risk assessment and cancer screening, including studies on cancer heredity and utilization of machine-learning/artificial intelligence in predicting risk.

Early detection, including studies on new technologies and biomarkers such as liquid biopsy, multicancer/multitarget assays applied in early detection settings, and “-omics” analyses of preneoplasia samples to detect cancer early.

Preclinical studies on preventive interventions and their mechanisms. Preventive interventions of interest include chemoprevention, immunoprevention (including checkpoint inhibitors, immunological approaches to prevention, and vaccination), and nutritional/behavioral prevention. Novel preclinical models (tissue culture and animals) to test preventive strategies are also of interest.

Clinical studies on preventive interventions. Articles may describe prevention-centric clinical trials at any phase.

Dissemination and implementation research. Studies should describe how to implement an evidence-based intervention, practice, or policy in a successful, highly impactful way. Relevant implementation-related concerns, such as effectiveness, efficiency, scaling, required personnel, and eligible participants, should be addressed.

Cancer disparities science that addresses the disproportionate risk that certain groups face. Groups may be affected by disparities on the basis of race, ethnicity, age, gender, sexual orientation/gender identity, socioeconomic status, insurance status, geographic residence, linguistic or cultural isolation, access to care, etc.

Health policy and global cancer control studies that are focused on the discovery or implementation of evidence-based interventions involving educational programs, infrastructures, and delivery of services addressing clinical or social needs to underserved communities.

Manuscript Submission

Cancer Prevention Research welcomes submission of original research and review articles to the journal. For descriptions and length requirements of the article types available to submitting authors, see the journal’s Categories of Articles.

The AACR Journals all use a similar Editorial Process and adhere to the same overarching Editorial Policies, both of which are detailed in the Instructions for Authors. These instructions contain important guidelines on authorship, publishing ethics, availability of materials and data, and data analysis and reporting. Authors should be familiar with these instructions prior to submitting their work to the journal.

Manuscripts are stringently reviewed for high standards of scientific merit, and only those articles that report results of novel, timely, and broadly significant research are accepted for publication.

Submit your article to Cancer Prevention Research

http://capr.msubmit.net/

Information for Authors

Select an AACR Journal

The nine AACR journals vary in scope and selectivity. If you are unsure which journal would be most appropriate for your manuscript, please review the journal descriptions on this page. Detailed metrics, including the Impact Factors, of all the AACR journals can be found at AACR Journals Metrics.

Editorial Process

This page has a brief overview of the basic editorial process used by all the AACR journals to evaluate submitted manuscripts. Our goal is to select for publication only those manuscripts that are determined by our editors and peer review process to be of the highest quality and within the scope of the journal to which the manuscript was submitted.

Editorial Policies

Please see this page for details of the editorial policies that govern manuscripts submitted to all AACR journals. These policies are intended to help ensure the integrity of the publication process and the research published by the AACR.

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/44359

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 杂志信息如有错漏 请在下方留言。

上一篇 2025年2月26日 下午11:22
下一篇 2025年2月26日 下午11:33

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

QQ:321628655
邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息